The impact of the Cancer Genome Atlas on lung cancer

被引：88
作者：
Chang, Jeremy T. -H.
Lee, Yee Ming
Huang, R. Stephanie
机构：
[1] Univ Chicago, Biol Sci Collegiate Div, Chicago, IL 60637 USA
[2] Univ Chicago, Ctr Personalized Therapeut, Chicago, IL 60637 USA
[3] Univ Chicago, Dept Med, Chicago, IL 60637 USA
来源：
TRANSLATIONAL RESEARCH | 2015年 / 166卷 / 06期
关键词：
MESSENGER-RNA; COPY NUMBER; TRANSCRIPTIONAL REGULATION; 1ST-LINE TREATMENT; TUMOR-SUPPRESSOR; OPEN-LABEL; EXPRESSION; GENE; CHEMOTHERAPY; MUTATION;
D O I：
10.1016/j.trsl.2015.08.001
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
The Cancer Genome Atlas (TCGA) has profiled more than 10,000 samples derived from 33 types of cancer to date, with the goal of improving our understanding of the molecular basis of cancer and advancing our ability to diagnose, treat, and prevent cancer. This review focuses on lung cancer as it is the leading cause of cancer-related mortality worldwide in both men and women. Particularly, non-small cell lung cancers (including lung adenocarcinoma and lung squamous cell carcinoma) were evaluated. Our goal was to demonstrate the impact of TCGA on lung cancer research under 4 themes: diagnostic markers, disease progression markers, novel therapeutic targets, and novel tools. Examples are given related to DNA mutation, copy number variation, messenger RNA, and microRNA expression along with methylation profiling.
引用
收藏
页码：568 / 585
页数：18
相关论文
共 105 条
  • [1] The Exomes of the NCI-60 Panel: A Genomic Resource for Cancer Biology and Systems Pharmacology
    Abaan, Ogan D.
    Polley, Eric C.
    Davis, Sean R.
    Zhu, Yuelin J.
    Bilke, Sven
    Walker, Robert L.
    Pineda, Marbin
    Gindin, Yevgeniy
    Jiang, Yuan
    Reinhold, William C.
    Holbeck, Susan L.
    Simon, Richard M.
    Doroshow, James H.
    Pommier, Yves
    Meltzer, Paul S.
    [J]. CANCER RESEARCH, 2013, 73 (14) : 4372 - 4382
  • [2] PIAS3 expression in squamous cell lung cancer is low and predicts overall survival
    Abbas, Rime
    McColl, Karen S.
    Kresak, Adam
    Yang, Michael
    Chen, Yanwen
    Fu, Pingfu
    Wildey, Gary
    Dowlati, Afshin
    [J]. CANCER MEDICINE, 2015, 4 (03): : 325 - 332
  • [3] EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
    Antonicelli, Alberto
    Cafarotti, Stefano
    Indini, Alice
    Galli, Alessio
    Russo, Andrea
    Cesario, Alfredo
    Lococo, Filippo Maria
    Russo, Patrizia
    Mainini, Alberto Franco
    Bonifati, Luca Giuseppe
    Nosotti, Mario
    Santambrogio, Luigi
    Margaritora, Stefano
    Granone, Pierluigi Maria
    Dutly, Andre Emanuel
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (03): : 320 - 330
  • [4] Intra-Tumour Signalling Entropy Determines Clinical Outcome in Breast and Lung Cancer
    Banerji, Christopher R. S.
    Severini, Simone
    Caldas, Carlos
    Teschendorff, Andrew E.
    [J]. PLOS COMPUTATIONAL BIOLOGY, 2015, 11 (03)
  • [5] Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
    Biankin, Andrew V.
    Waddell, Nicola
    Kassahn, Karin S.
    Gingras, Marie-Claude
    Muthuswamy, Lakshmi B.
    Johns, Amber L.
    Miller, David K.
    Wilson, Peter J.
    Patch, Ann-Marie
    Wu, Jianmin
    Chang, David K.
    Cowley, Mark J.
    Gardiner, Brooke B.
    Song, Sarah
    Harliwong, Ivon
    Idrisoglu, Senel
    Nourse, Craig
    Nourbakhsh, Ehsan
    Manning, Suzanne
    Wani, Shivangi
    Gongora, Milena
    Pajic, Marina
    Scarlett, Christopher J.
    Gill, Anthony J.
    Pinho, Andreia V.
    Rooman, Ilse
    Anderson, Matthew
    Holmes, Oliver
    Leonard, Conrad
    Taylor, Darrin
    Wood, Scott
    Xu, Qinying
    Nones, Katia
    Fink, J. Lynn
    Christ, Angelika
    Bruxner, Tim
    Cloonan, Nicole
    Kolle, Gabriel
    Newell, Felicity
    Pinese, Mark
    Mead, R. Scott
    Humphris, Jeremy L.
    Kaplan, Warren
    Jones, Marc D.
    Colvin, Emily K.
    Nagrial, Adnan M.
    Humphrey, Emily S.
    Chou, Angela
    Chin, Venessa T.
    Chantrill, Lorraine A.
    [J]. NATURE, 2012, 491 (7424) : 399 - 405
  • [6] Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: Implications for STAT-3 activation and gene expression
    Brantley, Emily C.
    Nabors, L. Burton
    Gillespie, G. Yancey
    Choi, Youn-Hee
    Palmer, Cheryl Ann
    Harrison, Keith
    Roarty, Kevin
    Benveniste, Etty N.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (15) : 4694 - 4704
  • [7] The mRNA-Destabilizing Protein Tristetraprolin Is Suppressed in Many Cancers, Altering Tumorigenic Phenotypes and Patient Prognosis
    Brennan, Sarah E.
    Kuwano, Yuki
    Alkharouf, Nadim
    Blackshear, Perry J.
    Gorospe, Myriam
    Wilson, Gerald M.
    [J]. CANCER RESEARCH, 2009, 69 (12) : 5168 - 5176
  • [8] Tristetraprolin (TTP): Interactions with mRNA and proteins, and current thoughts on mechanisms of action
    Brooks, Seth A.
    Blackshear, Perry J.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2013, 1829 (6-7): : 666 - 679
  • [9] p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-Neu oncogene-dependent breast tumorigenesis
    Cabodi, Sara
    Tinnirello, Agata
    Di Stefano, Paola
    Bisaro, Brigitte
    Ambrosino, Elena
    Castellano, Isabella
    Sapino, Anna
    Arisio, Riccardo
    Cavallo, Federica
    Forni, Guido
    Glukhova, Marina
    Silengo, Lorenzo
    Altruda, Fiorella
    Turco, Emilia
    Tarone, Guido
    Defilippi, Paola
    [J]. CANCER RESEARCH, 2006, 66 (09) : 4672 - 4680
  • [10] p130Cas is an essential transducer element in ErbB2 transformation
    Cabodi, Sara
    Tinnirello, Agata
    Bisaro, Brigitte
    Tornillo, Giusy
    Camacho-Leal, Maria del Pilar
    Forni, Guido
    Cojoca, Rodica
    Iezzi, Manuela
    Amici, Augusto
    Montani, Maura
    Eva, Alessandra
    Di Stefano, Paola
    Muthuswamy, Senthil K.
    Tarone, Guido
    Turco, Emilia
    Defilippi, Paola
    [J]. FASEB JOURNAL, 2010, 24 (10) : 3796 - 3808
12345678910